Ga-68 Pentixafor PET/CT in initial evaluation and response assessment to chemotherapeutic regimes in patients with multiple myeloma: First results and comparison with F-18 FDG PET/CT

被引：0
|
作者：
Kaur, H. [1 ]
Malhotra, P. [1 ]
Basher, R. [1 ]
Watts, A. [1 ]
Singh, H. [1 ]
Aggarwal, P. [1 ]
Singh, B. [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Chandigarh, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-019
引用
收藏
页码：S304 / S304
页数：1
相关论文
共 50 条
  • [21] Imaging CXCR4 receptors expression for staging multiple myeloma by using 68Ga-Pentixafor PET/CT: comparison with 18F-FDG PET/CT
    Shekhawat, Amit Singh
    Singh, Baljinder
    Malhotra, Pankaj
    Watts, Ankit
    Basher, Rajender
    Kaur, Harneet
    Hooda, Monika
    Radotra, Bishan D.
    BRITISH JOURNAL OF RADIOLOGY, 2022, 95 (1136):
  • [22] Case report of Multiple Myeloma: a comparison between 18F-FDG-PET/CT and 68Ga-PSMA-PET/CT
    Bezzi, D.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S12 - S13
  • [23] PET / CT Imaging in Smoldering Multiple Myeloma Patients F 18-Fluorodeoxyglucose and Ga68-Pentixafor: Preliminary results
    Korkmaz, U.
    Umit, E. G.
    Durmus-Altun, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S586 - S586
  • [24] GA-68 DOTA-OCTREOTATE (GATATE) AND F-18 FLUORODEOXYGLUCOSE (FDG) PET/CT IN THE ASSESSMENT OF PARAGANGLIOMAS AND PHEOCHROMOCYTOMAS
    Chang, C. A.
    Hofman, M.
    Thompson, M.
    Pattison, D.
    Hicks, R.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 7 - 7
  • [25] F-18 FDG PET/CT and F-18 FLT PET/CT as predictors of outcome in patients with multiple myeloma. A pilot study
    Gallicchio, R.
    Nardelli, A.
    Calice, G.
    Guarini, A.
    Guglielmi, G.
    Storto, G.
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 136
  • [26] Comparison of 18F-FDG PET/CT and PET/MRI for the assessment of multiple myeloma
    Sachpekidis, C.
    Hillengass, J.
    Goldschmidt, H.
    Mosebach, J.
    Schlemmer, H.
    Haberkorn, U.
    Dimitrakopoulou-Strauss, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S324 - S324
  • [27] Immunotherapy Response Assessment with F-18 FDG PET/CT in Metastatic Melanoma: First Results
    Herceg, G. Horvatic
    Simetic, L.
    Herceg, D.
    Ciglar-Hlasc, M.
    Lusic, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S37 - S37
  • [28] Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma; comparison to [18F]-FDG-PET/CT
    Tiryaki, T.
    Kuyumcu, S.
    Has-Simsek, D.
    Ozbalak, M.
    Ozluk, D.
    Unal, S.
    Kalayoglu-Besisik, S.
    LEUKEMIA RESEARCH, 2019, 85 : S24 - S24
  • [29] [68Ga]Pentixafor PET/CT imaging in cervical cancer, a comparison with [18F] FDG
    Hadebe, Bawinile
    Nxasana, Thembelihle
    Harry, Lerwine
    Patel, Maryam
    Ndlovu, Nontobeko
    Msimang, Mpumelelo
    Sathekge, Mike
    Masikane, Siphelele
    Gabela, Lerato
    Harry, Lerwine
    Vorster, Mariza
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [30] Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT
    İlknur Ak
    Hasan Onner
    Olga Meltem Akay
    Annals of Hematology, 2015, 94 : 1567 - 1575
12345